Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Borrelia miyamotoi Activates Human Dendritic Cells and Elicits T Cell Responses.

Mason LMK, Koetsveld J, Trentelman JJA, Kaptein TM, Hoornstra D, Wagemakers A, Fikrig MM, Ersoz JI, Oei A, Geijtenbeek TBH, Hovius JWR.

J Immunol. 2019 Dec 9. pii: ji1801589. doi: 10.4049/jimmunol.1801589. [Epub ahead of print]

PMID:
31818980
2.

Protective Immunity and New Vaccines for Lyme Disease.

Gomes-Solecki M, Arnaboldi PM, Backenson PB, Benach JL, Cooper CL, Dattwyler RJ, Diuk-Wasser M, Fikrig E, Hovius JW, Laegreid W, Lundberg U, Marconi RT, Marques AR, Molloy P, Narasimhan S, Pal U, Pedra JHF, Plotkin S, Rock DL, Rosa P, Telford SR, Tsao J, Yang XF, Schutzer SE.

Clin Infect Dis. 2019 Oct 17. pii: ciz872. doi: 10.1093/cid/ciz872. [Epub ahead of print]

PMID:
31620776
3.

Two Cases of Borrelia miyamotoi Meningitis, Sweden, 2018.

Henningsson AJ, Asgeirsson H, Hammas B, Karlsson E, Parke Å, Hoornstra D, Wilhelmsson P, Hovius JW.

Emerg Infect Dis. 2019 Oct;25(10):1965-1968. doi: 10.3201/eid2510.190416.

4.

Validation of cellular tests for Lyme borreliosis (VICTORY) study.

van de Schoor FR, Baarsma ME, Gauw SA, Joosten LAB, Kullberg BJ, van den Wijngaard CC, Hovius JW.

BMC Infect Dis. 2019 Aug 20;19(1):732. doi: 10.1186/s12879-019-4323-6.

5.

Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.

Koetsveld J, Platonov AE, Kuleshov K, Wagemakers A, Hoornstra D, Ang W, Szekeres S, van Duijvendijk GLA, Fikrig E, Embers ME, Sprong H, Hovius JW.

Clin Microbiol Infect. 2019 Aug 9. pii: S1198-743X(19)30418-5. doi: 10.1016/j.cmi.2019.07.026. [Epub ahead of print]

6.

A combination of antibodies against Bm86 and Subolesin inhibits engorgement of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae in vitro.

Trentelman JJA, Teunissen H, Kleuskens JAGM, van de Crommert J, de la Fuente J, Hovius JWR, Schetters TPM.

Parasit Vectors. 2019 Jul 25;12(1):362. doi: 10.1186/s13071-019-3616-3.

7.

Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission.

Rego ROM, Trentelman JJA, Anguita J, Nijhof AM, Sprong H, Klempa B, Hajdusek O, Tomás-Cortázar J, Azagi T, Strnad M, Knorr S, Sima R, Jalovecka M, Fumačová Havlíková S, Ličková M, Sláviková M, Kopacek P, Grubhoffer L, Hovius JW.

Parasit Vectors. 2019 May 14;12(1):229. doi: 10.1186/s13071-019-3468-x. Review.

8.

Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2019 May 2;9(1):7056. doi: 10.1038/s41598-019-42948-7.

9.

Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).

Vrijmoeth HD, Ursinus J, Harms MG, Zomer TP, Gauw SA, Tulen AD, Kremer K, Sprong H, Knoop H, Vermeeren YM, van Kooten B, Joosten LAB, Kullberg BJ, Hovius JWR, van den Wijngaard CC.

BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8.

10.

The role of Mannose Binding Lectin in the immune response against Borrelia burgdorferi sensu lato.

Coumou J, Wagemakers A, Narasimhan S, Schuijt TJ, Ersoz JI, Oei A, de Boer OJ, Roelofs JJTH, Fikrig E, Hovius JW.

Sci Rep. 2019 Feb 5;9(1):1431. doi: 10.1038/s41598-018-37922-8.

11.

Preliminary Evaluation of Tick Protein Extracts and Recombinant Ferritin 2 as Anti-tick Vaccines Targeting Ixodes ricinus in Cattle.

Knorr S, Anguita J, Cortazar JT, Hajdusek O, Kopáček P, Trentelman JJ, Kershaw O, Hovius JW, Nijhof AM.

Front Physiol. 2018 Dec 5;9:1696. doi: 10.3389/fphys.2018.01696. eCollection 2018.

12.

Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia.

Mihajlović J, Hovius JWR, Sprong H, Bogovič P, Postma MJ, Strle F.

Ticks Tick Borne Dis. 2019 Jan;10(1):63-71. doi: 10.1016/j.ttbdis.2018.08.014. Epub 2018 Aug 30.

13.

Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe.

Hoornstra D, Koetsveld J, Sprong H, Platonov AE, Hovius JW.

Emerg Infect Dis. 2018 Sep;24(9):1770-1772. doi: 10.3201/eid2409.180806.

14.

Case report: persistently seronegative neuroborreliosis in an immunocompromised patient.

Wagemakers A, Visser MC, de Wever B, Hovius JW, van de Donk NWCJ, Hendriks EJ, Peferoen L, Muller FF, Ang CW.

BMC Infect Dis. 2018 Aug 2;18(1):362. doi: 10.1186/s12879-018-3273-8.

15.

MRP8/14 does not contribute to dissemination or inflammation in a murine model of Lyme borreliosis.

Mason LMK, Coumou J, Ersöz JI, Oei A, Roelofs JJTH, Vogl T, van der Poll T, Hovius JWR.

Immunobiology. 2018 Nov;223(11):694-698. doi: 10.1016/j.imbio.2018.07.017. Epub 2018 Jul 17.

16.

In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi.

Koetsveld J, Manger A, Hoornstra D, Draga RO, Oei A, Kolyasnikova NM, Toporkova MG, Sarksyan DS, Wagemakers A, Platonov AE, Hovius JW.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00419-18. doi: 10.1128/AAC.00419-18. Print 2018 Jul.

17.

Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins.

Koetsveld J, Kolyasnikova NM, Wagemakers A, Stukolova OA, Hoornstra D, Sarksyan DS, Toporkova MG, Henningsson AJ, Hvidsten D, Ang W, Dessau R, Platonov AE, Hovius JW.

Clin Microbiol Infect. 2018 Dec;24(12):1338.e1-1338.e7. doi: 10.1016/j.cmi.2018.03.009. Epub 2018 Mar 14.

18.

Control of Lyme borreliosis and other Ixodes ricinus-borne diseases.

Sprong H, Azagi T, Hoornstra D, Nijhof AM, Knorr S, Baarsma ME, Hovius JW.

Parasit Vectors. 2018 Mar 6;11(1):145. doi: 10.1186/s13071-018-2744-5. Review.

19.

[Dilemma: to test or not to test for Lyme borreliosis in general practice].

Leeflang MMG, van Weert HCPM, Hovius JWR, Ang CW, Sprong H.

Ned Tijdschr Geneeskd. 2018;162:D2156. Dutch.

PMID:
29473537
20.

Whole-Genome Sequencing of Six Borrelia miyamotoi Clinical Strains Isolated in Russia.

Kuleshov KV, Koetsveld J, Goptar IA, Markelov ML, Kolyasnikova NM, Sarksyan DS, Toporkova MG, Kirdyashkina NP, Shipulin GA, Hovius JW, Platonov AE.

Genome Announc. 2018 Jan 4;6(1). pii: e01424-17. doi: 10.1128/genomeA.01424-17.

21.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis - Author's reply.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):211-212. doi: 10.1016/j.cmi.2017.10.011. Epub 2017 Oct 24. No abstract available.

22.

Investigating Human Dendritic Cell Immune Responses to Borrelia burgdorferi.

Mason LMK, Hovius JWR.

Methods Mol Biol. 2018;1690:291-299. doi: 10.1007/978-1-4939-7383-5_21.

PMID:
29032552
23.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):118-124. doi: 10.1016/j.cmi.2017.08.025. Epub 2017 Sep 5. Review.

24.

Lyme Borreliosis in Children: A Tertiary Referral Hospital-Based Retrospective Analysis.

Nassar-Sheikh Rashid A, Boele van Hensbroek M, Kolader M, Hovius JW, Pajkrt D.

Pediatr Infect Dis J. 2018 Feb;37(2):e45-e47. doi: 10.1097/INF.0000000000001735.

PMID:
28777206
25.

Modulation of the tick gut milieu by a secreted tick protein favors Borrelia burgdorferi colonization.

Narasimhan S, Schuijt TJ, Abraham NM, Rajeevan N, Coumou J, Graham M, Robson A, Wu MJ, Daffre S, Hovius JW, Fikrig E.

Nat Commun. 2017 Aug 4;8(1):184. doi: 10.1038/s41467-017-00208-0.

26.

Correction: Lyme borreliosis.

Steere AC, Franc S, Wormser GP, Hu LT, Branda JA, Hovius JWR, Li X, Mead PS.

Nat Rev Dis Primers. 2017 Aug 3;3:17062. doi: 10.1038/nrdp.2017.62.

PMID:
28770818
27.

In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.

Koetsveld J, Draga ROP, Wagemakers A, Manger A, Oei A, Visser CE, Hovius JW.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00535-17. doi: 10.1128/AAC.00535-17. Print 2017 Sep.

28.

Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.

van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P; AGEhIV Cohort Study Group.

Eur J Prev Cardiol. 2017 Aug;24(12):1297-1307. doi: 10.1177/2047487317714350. Epub 2017 Jun 5.

29.

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2017 Mar 22;7(1):303. doi: 10.1038/s41598-017-00412-4. Erratum in: Sci Rep. 2019 May 2;9(1):7056.

30.

Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.

Lankelma JM, Wagemakers A, Birnie E, Haak BW, Trentelman JJA, Weehuizen TAF, Ersöz J, Roelofs JJTH, Hovius JW, Wiersinga WJ, Bins AD.

Virulence. 2017 Nov 17;8(8):1683-1694. doi: 10.1080/21505594.2017.1307485. Epub 2017 Apr 19.

31.

Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe.

Jahfari S, Sarksyan DS, Kolyasnikova NM, Hovius JW, Sprong H, Platonov AE.

J Microbiol Methods. 2017 May;136:11-16. doi: 10.1016/j.mimet.2017.02.013. Epub 2017 Mar 1.

PMID:
28259789
32.

Development and optimization of an in vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever.

Koetsveld J, Kolyasnikova NM, Wagemakers A, Toporkova MG, Sarksyan DS, Oei A, Platonov AE, Hovius JW.

Clin Microbiol Infect. 2017 Jul;23(7):480-484. doi: 10.1016/j.cmi.2017.01.009. Epub 2017 Jan 18.

33.

Borrelia miyamotoi in vectors and hosts in The Netherlands.

Wagemakers A, Jahfari S, de Wever B, Spanjaard L, Starink MV, de Vries HJC, Sprong H, Hovius JW.

Ticks Tick Borne Dis. 2017 Mar;8(3):370-374. doi: 10.1016/j.ttbdis.2016.12.012. Epub 2016 Dec 30.

34.

Enzootic origins for clinical manifestations of Lyme borreliosis.

Jahfari S, Krawczyk A, Coipan EC, Fonville M, Hovius JW, Sprong H, Takumi K.

Infect Genet Evol. 2017 Apr;49:48-54. doi: 10.1016/j.meegid.2016.12.030. Epub 2016 Dec 28.

PMID:
28040562
35.

Lyme borreliosis.

Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, Li X, Mead PS.

Nat Rev Dis Primers. 2016 Dec 15;2:16090. doi: 10.1038/nrdp.2016.90. Review. Erratum in: Nat Rev Dis Primers. 2017 Aug 03;3:17062.

36.

Borrelia burgdorferi Induces TLR2-Mediated Migration of Activated Dendritic Cells in an Ex Vivo Human Skin Model.

Mason LM, Wagemakers A, van 't Veer C, Oei A, van der Pot WJ, Ahmed K, van der Poll T, Geijtenbeek TB, Hovius JW.

PLoS One. 2016 Oct 3;11(10):e0164040. doi: 10.1371/journal.pone.0164040. eCollection 2016.

37.

A Borrelia afzelii Infection Increases Larval Tick Burden on Myodes glareolus (Rodentia: Cricetidae) and Nymphal Body Weight of Ixodes ricinus (Acari: Ixodidae).

van Duijvendijk G, van Andel W, Fonville M, Gort G, Hovius JW, Sprong H, Takken W.

J Med Entomol. 2017 Mar 1;54(2):422-428. doi: 10.1093/jme/tjw157.

PMID:
27694145
38.

Imbalanced presence of Borrelia burgdorferi s.l. multilocus sequence types in clinical manifestations of Lyme borreliosis.

Coipan EC, Jahfari S, Fonville M, Oei GA, Spanjaard L, Takumi K, Hovius JW, Sprong H.

Infect Genet Evol. 2016 Aug;42:66-76. doi: 10.1016/j.meegid.2016.04.019. Epub 2016 Apr 25.

39.

Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi.

Wagemakers A, Koetsveld J, Narasimhan S, Wickel M, Deponte K, Bleijlevens B, Jahfari S, Sprong H, Karan LS, Sarksyan DS, van der Poll T, Bockenstedt LK, Bins AD, Platonov AE, Fikrig E, Hovius JW.

J Immunol. 2016 May 15;196(10):4185-95. doi: 10.4049/jimmunol.1600014. Epub 2016 Apr 13.

40.

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, Van Burgel ND, Van Dam AP, Dessau RB, Fingerle V, Hovius JW, Jaulhac B, Meijer B, Van Pelt W, Schellekens JF, Spijker R, Stelma FF, Stanek G, Verduyn-Lunel F, Zeller H, Sprong H.

BMC Infect Dis. 2016 Mar 25;16:140. doi: 10.1186/s12879-016-1468-4. Review.

41.

An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human Complement.

Wagemakers A, Coumou J, Schuijt TJ, Oei A, Nijhof AM, van 't Veer C, van der Poll T, Bins AD, Hovius JW.

Vector Borne Zoonotic Dis. 2016 Apr;16(4):223-8. doi: 10.1089/vbz.2015.1901. Epub 2016 Feb 22.

PMID:
26901751
42.

Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.

Salverda ML, Meinderts SM, Hamstra HJ, Wagemakers A, Hovius JW, van der Ark A, Stork M, van der Ley P.

Vaccine. 2016 Feb 17;34(8):1025-33. doi: 10.1016/j.vaccine.2016.01.019. Epub 2016 Jan 19.

PMID:
26801064
43.

Serological and molecular evidence for spotted fever group Rickettsia and Borrelia burgdorferi sensu lato co-infections in The Netherlands.

Koetsveld J, Tijsse-Klasen E, Herremans T, Hovius JW, Sprong H.

Ticks Tick Borne Dis. 2016 Mar;7(2):371-7. doi: 10.1016/j.ttbdis.2015.12.010. Epub 2015 Dec 17.

PMID:
26739030
44.

Ixodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut.

Coumou J, Narasimhan S, Trentelman JJ, Wagemakers A, Koetsveld J, Ersoz JI, Oei A, Fikrig E, Hovius JW.

J Mol Med (Berl). 2016 Mar;94(3):361-70. doi: 10.1007/s00109-015-1365-0. Epub 2015 Nov 23.

45.

Probability of Spirochete Borrelia miyamotoi Transmission from Ticks to Humans.

Sarksyan DS, Platonov AE, Karan LS, Shipulin GA, Sprong H, Hovius JW.

Emerg Infect Dis. 2015 Dec;21(12):2273-4. doi: 10.3201/eid2112.151097. No abstract available.

46.

Borrelia burgdorferi clinical isolates induce human innate immune responses that are not dependent on genotype.

Mason LM, Herkes EA, Krupna-Gaylord MA, Oei A, van der Poll T, Wormser GP, Schwartz I, Petzke MM, Hovius JW.

Immunobiology. 2015 Oct;220(10):1141-50. doi: 10.1016/j.imbio.2015.06.006. Epub 2015 Jun 17.

PMID:
26093919
47.

Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition.

Coumou J, Wagemakers A, Trentelman JJ, Nijhof AM, Hovius JW.

PLoS One. 2015 Apr 28;10(4):e0123495. doi: 10.1371/journal.pone.0123495. eCollection 2014.

48.

Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete.

Wagemakers A, Staarink PJ, Sprong H, Hovius JW.

Trends Parasitol. 2015 Jun;31(6):260-9. doi: 10.1016/j.pt.2015.03.008. Epub 2015 Apr 16. Review.

PMID:
25892254
49.

Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands.

Coumou J, Herkes EA, Brouwer MC, van de Beek D, Tas SW, Casteelen G, van Vugt M, Starink MV, de Vries HJ, de Wever B, Spanjaard L, Hovius JW.

Clin Microbiol Infect. 2015 Apr;21(4):368.e11-20. doi: 10.1016/j.cmi.2014.11.014. Epub 2014 Nov 22.

50.

High seroprevalence of Borrelia miyamotoi antibodies in forestry workers and individuals suspected of human granulocytic anaplasmosis in the Netherlands.

Jahfari S, Herremans T, Platonov AE, Kuiper H, Karan LS, Vasilieva O, Koopmans MP, Hovius JW, Sprong H.

New Microbes New Infect. 2014 Sep;2(5):144-9. doi: 10.1002/nmi2.59. Epub 2014 Sep 6.

Supplemental Content

Loading ...
Support Center